MGRX
Mangoceuticals, Inc.
Set alert
0.23 USD -0.02 -8.22%
0.2292 Day range 0.2595
0.162 52-week range 2.21
- YTD
- -68.46%
- 1 year
- -88.61%
- Open
- 0.257
- Prev close
- 0.2543
- Mkt cap
- 5.19M
- Vol
- 531.82K
- Avg vol
- 11.53M
- EPS
- -1.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2292
- High
- 0.2595
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.21
- Inst. own
- 4.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.49
- 200-d avg
- 3.94
- 1y target
- 0.00
Financial health
Altman Z-Score
-6.10 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2021 5y median -0.6× FY 2025
P/S 16.3×
FY 2021 5y median 8.1× FY 2025
P/B 0.5×
FY 2021 5y median 0.5× FY 2025
P/FCF -1.3×
FY 2021 5y median -1.3× FY 2025
EV/EBITDA -0.3×
FY 2021 5y median -0.7× FY 2025
EV/Sales 13.8×
FY 2021 5y median 8.0× FY 2025
FCF Yield -78.5%
FY 2021 5y median -78.5% FY 2025
Profitability
Gross Margin 54.9%
FY 2021 5y median 54.9% FY 2025
Operating Margin -4200.5%
FY 2021 5y median -1294.4% FY 2025
Net Margin -4526.9%
FY 2021 5y median -1413.6% FY 2025
ROE -135.8%
FY 2021 5y median -135.8% FY 2025
ROIC -123.5%
FY 2021 5y median -123.5% FY 2025
ROA -128.3%
FY 2021 5y median -128.3% FY 2025
Growth (YoY)
Revenue -26.0%
FY 2021 FY 2025
Operating Income -140.3%
FY 2021 FY 2025
EPS (diluted) 50.7%
FY 2021 FY 2025
Free Cash Flow -20.3%
FY 2021 FY 2025
Financial Health
Current Ratio 1.7×
FY 2021 5y median 1.7× FY 2025
Quick Ratio 1.7×
FY 2021 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2021 5y median 0.1× FY 2025
Interest Coverage -185×
FY 2021 5y median -185× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31